Isomab Ltd ("Isomab") a UK-based biotechnology company developing novel therapies to restore vascularization in ...

CryoTherapeutics announced treatment of the first patient in its ICECAP study, an important step in evaluating localized ...

EXXUA net revenue was $6.6 million during fiscal 2026. EXXUA was made commercially available in mid-December 2025, and more formally launched in mid-January 2026 following the completion of sales ...

Even when a doctor tells you to 'take medication to thin your blood,' many people feel anxious about what diseases it is meant to prevent and what they should be careful about.In this article, we will ...

Medicare covers cardiac rehab after a heart attack, but the same 12 weeks of treatment at two different facilities can produce two very different total bills, and most patients choose a location ...

Swedish developer Star Stable Entertainment has laid off 20% of its employees following a restructuring program. In a statement on LinkedIn, interim CEO James Watkins said "this step is necessary to ...

On August 28, 2026, the European Society of Cardiology (ESC) released the new heart failure clinical practice guidelines, ...

Study finds device brings significant fall in chest pain in 75% of patients, but further trials and NHS approval are needed “It’s an amazing relief, both physically and emotionally, to be able to live ...

Emergency Diagnosis: Hospitals need faster troponin and ECG workflows for suspected ACS patients. PCI Capacity: Cardiac centers use catheterization labs to treat high-risk coronary events. Secondary ...

Overall, serious adverse events occurred in 3.9% of patients over the 6-month study period. Use of relugolix among patients with prostate cancer is associated with stable quality of life (QoL), high ...

You may want to have a say in this decision, or you may simply want to follow your doctor's recommendation. Either way, this information will help you understand what your choices are so that you can ...